AMBRA1 was recently described as a potent tumor suppressor, which regulates the stability of D-type cyclins and S phase entry, and loss of AMBRA1 has been suggested to decrease sensitivity to CDK4/6 blockade [40–42]. The gene discussed is CDK4; the disease is neoplasm.